Gastric Cancer
A PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR ESOPHAGEAL ADENOCARCINOMA: C6461016
- Details
ClinicalTrials.gov ID:
NCT07392892
Diagnosis Type:
NA
USOR Number:
- Address
,
P: